Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists

被引:13
|
作者
Vidal, Benjamin [1 ]
Bolbos, Radu [2 ]
Redoute, Jerome [2 ]
Langlois, Jean-Baptiste [2 ]
Costes, Nicolas [2 ]
Newman-Tancredi, Adrian [3 ]
Zimmer, Luc [1 ,2 ,4 ,5 ]
机构
[1] Univ Lyon, Lyon Neurosci Res Ctr, CNRS, INSERM, Bron, France
[2] CERMEP Imagerie Vivant, Bron, France
[3] Neurolixis SAS, Castres, France
[4] Hosp Civils Lyon, Lyon, France
[5] Natl Inst Nucl Sci & Technol, Saclay, France
关键词
5-HT1A receptor; NLX-112; NLX-101; Biased agonism; phMRI; fMRI; SIGNAL-TRANSDUCTION; IN-VIVO; RAT-BRAIN; NLX-112; MODULATION; F-13640; PROFILE; F15599; MODEL;
D O I
10.1016/j.neuropharm.2019.107867
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The emerging concept of "biased agonism" denotes the phenomenon whereby agonists can preferentially direct receptor signalling to specific intracellular responses among the different transduction pathways, thus potentially avoiding side effects and improving therapeutic effects. The aim of this study was to investigate biased agonism by using pharmacological magnetic resonance imaging (phMRI). The cerebral blood oxygen level dependent (BOLD) signal changes induced by increasing doses of two serotonin 5-HT1A receptor biased agonists, NLX-112 and NLX-101, were mapped in anaesthetized rats. Although both compounds display high affinity, selectivity and agonist efficacy for 5-HT1A receptors, NLX-101 is known to preferentially activate post-synaptic receptors, whereas NLX-112 targets both pre- and post-synaptic receptors. We used several doses of agonists in order to determine if the regional selectivity of NLX-101 was dose-dependent. NLX-112 and NLX-101 induced different positive and negative hemodynamic changes patterns at equal doses. Importantly, NLX-101 had no significant effect in regions expressing presynaptic receptors contrary to NLX-112. NLX-112 also produced higher BOLD changes than NLX-101 in the orbital cortex, the somatosensory cortex, and the magnocellular preoptic nuclei. In other regions such as the retrosplenial cortex and the dorsal thalamus, the drugs had similar effects. In terms of functional connectivity, NLX-112 induced more widespread changes than NLX-101. The present phMRI study demonstrates that two closely-related agonists display notable differences in their hemodynamic "fingerprints". These data support the concept of biased agonism at 5-HT1A receptors and raise the prospect of identifying novel therapeutics which exhibit improved targeting of brain regions implicated in neuropsychiatric disorders. This article is part of the special issue entitled 'Serotonin Research: Crossing Scales and Boundaries'.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?
    Salaciak, Kinga
    Pytka, Karolina
    PHARMACOLOGY & THERAPEUTICS, 2021, 227
  • [12] Simultaneous PET/MR Imaging for the Exploration of Serotonin 5-HT1A Receptor Biased Agonists
    Vidal, Benjamin
    Fieux, Sylvain
    Redoute, Jerome
    Le Bars, Didier
    Newman-Tancredi, Adrian
    Costes, Nicolas
    Zimmer, Luc
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S581 - S581
  • [13] 5-HT1A and 5-HT1B receptor agonists and aggression:: A pharmacological challenge of the serotonin deficiency hypothesis
    de Boer, SF
    Koolhaas, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 526 (1-3) : 125 - 139
  • [14] 5-HT1A agonists
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (10) : 969 - 970
  • [15] Serotonin 5-HT1A receptor biased agonists: The challenge of translating an innovative neuropharmacological concept into therapeutics
    Zimmer, Luc
    Newman-Tancredi, Adrian
    NEUROPHARMACOLOGY, 2025, 265
  • [16] The functional change in the 5-HT1A receptor induced by stress and the role of the 5-HT1A receptor in neuroprotection
    Miyagawa, K
    Narita, M
    Miyatake, M
    Suzuki, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 128P - 128P
  • [17] Functional characterisation of agonists at serotonin 5-HT1A receptors
    McLoughlin, DJ
    Strange, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P296 - P296
  • [18] Discovery of a new series of 5-HT1A receptor agonists
    Franchini, Silvia
    Prandi, Adolfo
    Sorbi, Claudia
    Tait, Annalisa
    Baraldi, Annamaria
    Angeli, Piero
    Buccioni, Michela
    Cilia, Antonio
    Poggesi, Elena
    Fossa, Paola
    Brasili, Livio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 2017 - 2020
  • [19] NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS
    MILLAN, MJ
    CANTON, H
    GOBERT, A
    LEJEUNE, F
    RIVET, JM
    BERVOETS, K
    BROCCO, M
    WIDDOWSON, P
    MENNINI, T
    AUDINOT, V
    HONORE, P
    RENOUARD, A
    LEMAROUILLEGIRARDON, S
    VERRIELE, L
    GRESSIER, H
    PEGLION, JL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (01): : 337 - 352
  • [20] FUNCTIONAL SELECTIVITY OF 5-HT2C RECEPTOR AGONISTS
    Pausch, Mark
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 339 - 339